Bart Scott, M.D.

Bart Scott M.D.
faculty member

Bart Scott, M.D.

Associate Member, Transplantation Program
Clinical Research Division, Fred Hutch

Fax: 206.667.6124
Mail Stop: D1-100

Dr. Bart Scott specializes in treating patients with myelodysplastic syndromes, or MDS, and myeloproliferative neoplasms, or MPN. These are a collection of diseases in which the bone marrow produces either too many or too few mature blood cells. Dr. Scott studies ways to improve treatment strategies for these patients, in particular new combinations of conditioning regimens prior to blood stem cell transplant.

Other Appointments & Affiliations

Clinical Director, MDS/MPN and Myeloid Malignancies
Seattle Cancer Care Alliance

Assistant Professor, Oncology
University of Washington School of Medicine

Education

B.S., Biology and Chemistry, University of Alabama at Birmingham, 1991

M.D., University of South Alabama, 1996

Research Interests

Clinical trials for myelodysplastic syndrome and myeloproliferative disorders

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.